FFO
UTMD icon

Fortitude Family Office’s Utah Medical Products UTMD Stock Holding History

Fortitude Family Office’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03K Buy
15
+5
+50% +$332 ﹤0.01% 1746
2026
Q1 		$620 Hold
10
– – ﹤0.01% 1647
2025
Q4 		$560 Sell
10
-202
-95% -$11.7K ﹤0.01% 1667
2025
Q3 		$13.3K Hold
212
– – ﹤0.01% 488
2025
Q2 		$12.1K Buy
+212
New +$11.5K ﹤0.01% 497

Other funds holding UTMD

CCMINC
Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Fortitude Family Office's UTMD Position: Q2 2026 in Review

Fortitude Family Office increased its Utah Medical Products (UTMD) stake by 50% in Q2 2026, buying an estimated $332 and bringing the position to 15 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1746.

Fortitude Family Office first reported a position in UTMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $13.3K in Q3 2025. 15 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Fortitude Family Office held 15 shares of Utah Medical Products worth $1.03K as of Q2 2026.
  • Fortitude Family Office bought 5 Utah Medical Products shares in Q2 2026, an estimated $332.
  • Utah Medical Products made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1746 holding.
  • Fortitude Family Office first reported a position in Utah Medical Products in Q2 2025 and has held it in 5 quarters since.
  • Fortitude Family Office's Utah Medical Products position peaked at $13.3K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.